Effect of serotonin reuptake inhibitor on syndrome development in obese hyperglycemic mice (Umeå ob/ob)

Metabolism: Clinical and Experimental

Volumn 50, Issue 2, 2001, Pages 144-150

  Thrybom, Tobias ^a,b   Rooth, Pål ^a,b   Lindström, Per ^a,b  

^a UMEÅ UNIVERSITY   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; GLUCOSE; INSULIN; LEPTIN; SEROTONIN UPTAKE INHIBITOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG DETERMINATION; FECES; FEEDING BEHAVIOR; FEMALE; FOOD INTAKE; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; HYPERPHAGIA; INSULIN BLOOD LEVEL; LANGERHANS CELL; MALE; METABOLIC RATE; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN DEFECT; SEROTONINERGIC SYSTEM; WEIGHT GAIN; WEIGHT REDUCTION;

EID: 0035109854     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1053/meta.2001.20175     Document Type: Article

References (36)

1. Drugs that enhance central serotoninergic transmission diminish elective carbohydrate consumption by rats
2. Clinical studies with fluoxetine in obesity
3. Serotonin neuronal function and selective serotonin reuptake inhibitor treatment in anorexia and bulimia nervosa
4. Sertraline enhances the effects of cognitive-behavioral treatment on weight reduction of obese patients
5. Selective serotonin-reuptake inhibitors: An update
6. Citalopram: A review of its pharmacology, clinical efficacy and tolerability in the treatment of depression
7. Positional cloning of the mouse obese gene and its human homologue
8. Weight-reducing effects of the plasma protein encoded by the obese gene
9. Effects of the obese gene product on body weight regulation in ob/ob mice
10. Metabolic, nutritional and endocrine studies of the hereditary obesity-diabetes syndrome of mice and mechanism of its development
11. Familial diabetes mellitus in mice, associated with insulin resistance, obesity and hyperplasia of the islands of Langerhans
12. Compensatory growth of pancreatic B-cells in adult rats after short-term glucose infusion
13. Leptin and reproduction
14. Anorectic effect of fenfluramine, cholecystokinin and neurotensin in genetically obese (ob/ob) mice
15. Differential effects of NE, CLON, and 5-HT on feeding and macronutrient selection in genetically obese (ob/ob) and lean mice
16. Vagotomy in young obese hyperglycemic mice: Effects on syndrome development and islet proliferation
17. Measurements of serum glucose using the luciferin/luciferase system and a liquid scintillation spectrometer
18. Hypothalamic serotonin in control of eating behavior, meal size, and body weight
19. Plasma amino acids and insulin levels in obesity: Response to carbohydrate intake and tryptophan supplements
20. Prior carbohydrate consumption affects the amount of carbohydrate that rats choose to eat
21. Obese, a new mutation in the house mouse
22. Development of the obese-hyperglycemic syndrome in mice
23. Relationship between brain serotonin and calmodulin in young, genetically obese (ob/ob) mice
24. Leptin induced both hyperphagia and type 2 diabetes in mice with a mutated serotonin 5-HT2C receptor gene
25. Effect of leptin deficiency on metabolic rate in ob/ob mice
26. Leptin alters metabolic rates before acquisition of its anorectic effects in developing neonatal mice
27. Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding
28. Behavioral profiles of SSRIs in animal models of depression, anxiety and aggression. Are they all alike?
29. Citalopram-induced hypophagia is enhanced by blockade of 5-HT(1A) receptors: Role of 5-HT(2C) receptors
30. Effects of sertraline and citalopram given repeatedly on the responsiveness of 5-HT receptor subpopulations
31. Selective serotonin reuptake inhibitors dissociate fenfluramine's anorectic and neurotoxic effects: Importance of dose, species and drug
32. Nicotinic acetylcholine receptor antagonistic activity of monoamine uptake blockers in rat hippocampal slices
33. Effects of antidepressant drugs on the dopamine D2/D3 receptors in the rat brain differentiated by agonist and antagonist binding-an autoradiographic analysis
34. Fluoxetine increases extracellular dopamine in the prefrontal cortex by a mechanism not dependent on serotonin: A comparison with citalopram
35. Central nervous system control of food intake